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1. Introduction
  Dengue virus (DENV) is a single-stranded RNA 
virus belonging to the genus Flavivirus and the family 
Flaviviridae.  Dengue virus infection is an increasing cause 
of morbidity and mortality in tropical and subtropical 
countries. Patients infected with dengue viruses can be 
asymptomatic or present with two forms of illness, dengue 
fever (DF) and dengue hemorrhagic fever (DHF).
  DF i s  a  se l f-l imi ted  febr i le  i l lness .  Pat ients 
may demonstrate fever,  headache, myalgias and 
thrombocytopenia and recover from the symptoms 
about a week after disease onset. Some patients 
infected with dengue virus demonstrate plasma leakage, 
thrombocytopenia, and hemorrhagic manifestation. This 
severe syndrome is called DHF[1].
  Pathologies observed in DHF can be mediated by the 
virulence of infecting viruses and by host immune response. 
It has been shown that plasma leakage is caused by 
vascular endothelial cell damage from the immune response 
to dengue virus infection[2]. Tumor necrotic factor-毩 (TNF-
毩) has been known to be involved in plasma leakage. 
Monocytes and endothelial cells infected with dengue 
viruses produced TNF-毩[2, 3]. Monocytes produced TNF-毩 
in the presence of enhancing antibody and the produced TNF-
毩 induced plasma leakage in in vitro experiments[4]. Levels 
of plasma cytokines such as TNF-毩, IL-2, IL-6, IL-8, IL-12 
and IFN-毭 were significantly higher in DHF than in DF[5]. It 
has been shown that mast cells and basophil infected with 
dengue virus  produced IL-1 and IL-6[6]. Dengue virus-specific T 
lymphocytes also secreted  IFN-毭, IL-2 and TNF-毩[2, 7].  These 
suggested that various cell types are involved in increased 
cytokine production.
  In addition, it has been demonstrated that the levels of 
IL-6 and IL-1 receptor antagonist were higher in DSS non-
survivors than in the survivors.  The level of IL-1 receptor 
antagonist was shown to associate with disease mortality[8]. 
IL-1毬, IFN-毭, IL-4, IL-6, IL-13, IL-7 and granulocyte-
macrophage colony stimulating factor (GM-CSF) were 
significantly increased in patients with severe manifestations 
compared with patients with mild disease. IL-1毬, IL-8, 
TNF-毩 and monocyte-chemotactic protein-1 (MCP-1) were 
associated with marked thrombocytopenia.  Bozza et al 
demonstrated that macrophage inflammatory protein-1beta 
(MIP-1毬) was a good prognostic marker whereas IFN-毭 
was associated with disease severity[9].
  The increase of cytokines in dengue virus infection can be 
the results of the increased cytokine production or down-
regulation of cytokine regulator. IL-18 is a member of the 
IL-1 family. It was originally known as an interferon-gamma 
inducing cytokine. IFN-毭enhances macrophage, natural 
killer (NK) cell and cytotoxic T cell activity. For those 
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reasons, IL-18 has been studied as a cytokine involved in 
host defense especially in killing of intracellular organisms 
and eradication of cancer cells. The predominant cell 
sources of IL-18 are macrophages and dendritic cells[10]. IL-
18 binding protein (BP) is a natural IL-18 antagonist. Binding 
of IL-18BP to IL-18 prevents IL-18 from binding to IL-18R毩 
on the target cell membrane[11]. Functional homologues of 
human IL-18BP encoded by viruses such as orthopoxviruses 
have been shown  to inhibit IL-18 activity[12]. There are four 
isotypes (IL-18BPa, b, c and d) of human IL-18BP generated 
from alternative mRNA splicing.Only IL-18BPa and IL-18BPc 
have intact Ig-like domains and can neutralize IL-18. The 
role of the other two isoforms is still unknown[13].
  The level of IFN-毭, a T helper 1 cytokine, has been shown 
to correlate with severity of dengue virus infection[9]. IL-18 is 
an IFN-毭 inducing cytokine and its level was increased in 
patients with dengue virus infection. Moreover, the level of 
IL-18 correlates with disease severity[14]. IL-18 neutralization 
by IL-18BP regulates IL-18 activity resulting in controlling 
immune response induced by IFN-毭. Regulation of IL-18 by 
its natural inhibitor could be another promising tool for the 
development of disease therapy.  In this study, the levels of 
serum IL-18 and IL-18BP were determined in patients with 
DF and DHF.
 
2. Materials and methods
  The study protocol was approved by the Ethical Committee, 
Faculty of Medicine, Chulalongkorn University. 
2.1. Specimens
  Sera from patients with suspected dengue virus infection 
were obtained from the Center of Excellence in Clinical 
Virology, Faculty of Medicine, Chulalongkorn University. 
  Paired sera positive by IgM ELISA and RT-PCR for dengue 
virus were included in this study. The samples were divided 
into DF and DHF groups which were composed of 32 and 48 
pairs of sera, respectively.
2.2. Determination of IL-18 and IL-18BP levels by captured 
ELISA 
  The levels of IL-18 and IL-18BP were determined by 
captured ELISA purchased from MBL (Nagoya, Japan) and 
R&D Systems (MN, USA), respectively. The assays were 
performed according to the manufacturer’s instruction. 
Briefly, for IL-18 determination, sera and standard solution 
were added into anti-IL-18-coated wells. IL-18 was then 
captured by anti-IL-18 conjugated with peroxidase  and 
the presence of IL-18 was demonstrated by adding TMB 
substrate.  The absorbance at 450/620 nm was read by a dual 
wavelength plate reader. A standard curve was constructed 
and the concentration of IL-18 in samples was read from the 
standard curve.
  For determining the level of IL-18BP, the microtiter plate 
was coated with antibody to IL-18BPa, the isoform with 
widely known IL-18 neutralizing activity. The plate was 
blocked with 1%BSA in phosphate buffer saline. Sera and 
standard solution were then added. IL-18BPa was captured 
by adding biotinylated anti-IL-18BPa. The presence of IL-
18BPa was demonstrated by adding streptavidin-horse 
radish peroxidase followed by TMB substrate. Absorbance at 
450/570 nm was read and the standard curve was constructed 
according to the manufacturer’s suggestion. The IL-18BPa 
level was read from the standard curve.  
2.3. Statistical analysis
  Paired t-test was used to demonstrate the difference 
between IL-18 or IL-18BP levels in acute and convalescent 
sera. The difference between the levels in control and patient 
groups and between DF and DHF group was determined by 
unpaired t-test. P-values <0.05 were considered statistically 
different.  
3. Results 
  The levels of IL-18 and IL-18BP in 20 sera from healthy 
blood donors were determined by the same reagents and 
methods used in this study and previously reported[15]. IL-
18 and IL-18BP levels in control, DF and DHF groups were 
shown in Table 1 and Figure 1. Levels of IL-18 and IL-18BP 
in sera from patients with dengue virus infection, both DF 
and DHF groups, were statistically higher than the levels 
in sera from the control group (P<0.001). This suggested an 
increase in IL-18 and IL-18BP levels following dengue virus 
infection. 
  In both DF and DHF groups, the mean of IL-18 level in 
convalescent sera was lower than in acute sera. However, 
the lower levels observed were not statistically different. 
In contrast, the levels of IL-18BP in convalescent sera were 
significantly lower than the levels in acute sera (P<0.001 for 
both DF and DHF groups).  
  The ratios between IL-18/IL-18BP levels were determined. 
There was no statistically difference between the ratio of 
IL-18 and IL-18BP levels in acute and convalescent sera. 
The levels of IL-18, IL-18BP and IL-18/IL-18BP ratio were 
compared between DF and DHF groups. There was no 
statistically difference observed.
4. Discussion
  IL-18 promotes IFN-毭 production and the level of IFN-毭 has 
been shown to associate with disease severity[9].According 
to our data, both IL-18 and IL-18BP levels were increased 
in patients with dengue virus infection when compared 
with controls. This demonstrated that dengue virus 
infection induces IL-18 and IL-18BP production. IL-18BP
is a natural regulator of IL-18 and is induced by IFN-毭. 
This suggests that IFN-毭 provides the negative feedback 
for IL-18 suppression by inducing IL-18BP production. 
Although the levels of IL-18BP were increased following 
infection, the levels of IL-18BP were lower in convalescent 
sera than in acute sera. The lower level of IL-18BP in 
convalescent sera was probably due to the loss following IL-
18 neutralization. The proposed mechanism of IL-18 and 
IL-18BP involvement in dengue virus infection might be: 
Dengue virus infection induces IL-18 secretion resulting in 
Table 1
Summary of IL-18 and IL-18BP levels (mean依SD).
Infection IL-18 (pg/mL)
IL-18BP
(ng/mL)
IL-18/IL-18BP
DF Acute 695.56 依 349.76 2.75 依 1.32 0.31 依 0.20
Convalescent 626.94 依 357.01 2.15 依 0.94 0.34 依 0.26
DHF Acute 625.00 依 301.75 2.93 依 1.47 0.28 依 0.22
Convalescent 585.16 依 315.43 2.32 依 1.20 0.32 依 0.23
Control 62.95 依 36.63 0.50 依 0.12  -
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enhanced IFN-毭 production. The increased IFN-毭 induces 
IL-18BP production. IL-18BP negatively regulates Th1 
response by neutralizing IL-18 activity. Although IL-18BP 
production was enhanced when compared with the controls, 
its amount was still not sufficient to significantly reduce the 
level of IL-18 in the course of infection.  In addition, while 
IL-18BP was reduced, IL-18 level could probably be induced 
continuously.
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Figure 1.  Comparison of IL-18 and IL-18BP levels in control, acute 
and convalescent sera. 
The levels of IL-18 (A and B) and IL-18BP (C and D) in sera from 
control group and in acute and convalescent sera from patients with 
dengue virus infection, DF (A and C) and DHF (B and D) groups, 
were determined by captured ELISA as described in Materials and 
methods.    
  The inhibition of IL-18 activity by IL-18BP could be 
one of the mechanisms that regulate immune response.
Imbalance between IL-18 and IL-18BP production could 
be the underlying cause of immunopathological diseases. 
In this study, the levels of IL-18 and IL-18BP and the ratio 
of IL-18/IL-18BP were not statistically different among 
patients with DF and DHF. It is possible that DHF samples 
obtained in this study were from grade I and grade II DHF 
patients.Further investigating in samples from patients 
with more severe forms of disease could better suggest 
whether the levels of IL-18 and IL-18BP or their ratio are 
useful for disease prognosis. However, the results of this 
study suggested the involvement of IL-18BP, a natural IL-
18 regulator, in immune response following dengue virus 
infection. Understanding the immune response to dengue 
virus infection will provide further information for safe and 
effective vaccine development. 
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